Literature DB >> 17362570

Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting.

Anne Szarewski1, Louise Cadman, Susan Mallett, Janet Austin, Philip Londesborough, Jo Waller, Jane Wardle, Douglas G Altman, Jack Cuzick.   

Abstract

OBJECTIVES: To compare the performance and acceptability of unsupervised self-sampling with clinician sampling for high-risk human papillomavirus (HPV) types for the first time in a UK screening setting.
SETTING: Nine hundred and twenty women, from two demographically different centres, attending for routine cervical smear testing.
METHODS: Women performed an unsupervised HPV self-test. Immediately afterwards, a doctor or nurse took an HPV test and cervical smear. Women with an abnormality on any test were offered colposcopy.
RESULTS: Twenty-one high-grade and 39 low-grade cervical intraepithelial neoplasias (CINs) were detected. The sensitivity for high-grade disease (CIN2+) for the self HPV test was 81% (95% confidence interval [CI] 60-92), clinician HPV test 100% (95% CI 85-100), cytology 81% (95% CI 60-92). The sensitivity of both HPV tests to detect high- and low-grade cervical neoplasia was much higher than that of cytology (self-test 77% [95%CI 65-86], clinician test 80% [95% CI 68-88], cytology 48% [95% CI 36-61]). For both high-grade alone, and high and low grades together, the specificity was significantly higher for cytology (greater than 95%) than either HPV test (between 82% and 87%). The self-test proved highly acceptable to women and they reported that the instructions were easy to understand irrespective of educational level.
CONCLUSIONS: Our results suggest that it would be reasonable to offer HPV self-testing to women who are reluctant to attend for cervical smears. This approach should now be directly evaluated among women who have been non-attenders in a cervical screening programme.

Entities:  

Mesh:

Year:  2007        PMID: 17362570      PMCID: PMC4109399          DOI: 10.1258/096914107780154486

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  17 in total

1.  Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.

Authors:  Akhila Balasubramanian; Shalini L Kulasingam; Atar Baer; James P Hughes; Evan R Myers; Constance Mao; Nancy B Kiviat; Laura A Koutsky
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

2.  Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening.

Authors:  Constance Mao; Shalini L Kulasingam; Hilary K Whitham; Stephen E Hawes; John Lin; Nancy B Kiviat
Journal:  J Womens Health (Larchmt)       Date:  2017-03-23       Impact factor: 2.681

3.  Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women.

Authors:  Romy van Baars; Remko P Bosgraaf; Bram W A ter Harmsel; Willem J G Melchers; Wim G V Quint; Ruud L M Bekkers
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

Review 4.  Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.

Authors:  Patti E Gravitt; Jerome L Belinson; Jorge Salmeron; Keerti V Shah
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

5.  Improving behaviour in self-testing (IBIS): Study on frequency of use, consequences, information needs and use, and quality of currently available consumer information (protocol).

Authors:  Janaica E J Grispen; Martine H P Ickenroth; Nanne K de Vries; Geert-Jan Dinant; Gaby Ronda; Trudy van der Weijden
Journal:  BMC Public Health       Date:  2010-08-03       Impact factor: 3.295

6.  Acceptability of cervical and anal HPV self-sampling in a sample of Hispanic women in Puerto Rico.

Authors:  Ana P Ortiz; Natalia Alejandro; Cynthia M Pérez; Yomayra Otero; Marievelisse Soto-Salgado; Joel M Palefsky; Guillermo Tortolero-Luna; Josefina Romaguera
Journal:  P R Health Sci J       Date:  2012-12       Impact factor: 0.705

7.  Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening.

Authors:  Charlotte H Lenselink; Roosmarie P de Bie; Dennis van Hamont; Judith M J E Bakkers; Wim G V Quint; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

8.  Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling.

Authors:  Anna-Barbara Moscicki; Lea Widdice; Yifei Ma; Sepideh Farhat; Susanna Miller-Benningfield; Janet Jonte; Julie Jay; Cheryl Godwin de Medina; Evelyn Hanson; Lisa Clayton; Stephen Shiboski
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

9.  The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600).

Authors:  P Giorgi Rossi; L M Marsili; L Camilloni; A Iossa; A Lattanzi; C Sani; C Di Pierro; G Grazzini; C Angeloni; P Capparucci; A Pellegrini; M L Schiboni; A Sperati; M Confortini; C Bellanova; A D'Addetta; E Mania; C B Visioli; E Sereno; F Carozzi
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

10.  Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.

Authors:  Fang-Hui Zhao; Adam K Lewkowitz; Feng Chen; Margaret J Lin; Shang-Ying Hu; Xun Zhang; Qin-Jing Pan; Jun-Fei Ma; Mayineur Niyazi; Chang-Qing Li; Shu-Min Li; Jennifer S Smith; Jerome L Belinson; You-Lin Qiao; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2012-01-23       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.